US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
アメリカ
USOTC
MYND Life Sciences Inc (EM) (MYNDF) 銘柄情報

MYND Life Sciences Inc (EM) (MYNDF)

0.0081

0.00

( 0.00% )

更新日時： 09:00:00

MYND Life Sciences Inc (EM) (MYNDF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.0081

( - )

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

0.0073 52 週間の範囲 0.03

時価総額

前日終値

0.0081

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 0

発行済株式数

74,547,806

配当利回り

PER

-6.02

1 株当たり利益 (EPS)

-0.01

歳入

1

純利益

-542.57k

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psiloc... MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.myndsciences.com

本社

Port Coquitlam, Canada

設立

-

MYND Life Sciences Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker MYNDF. The last closing price for MYND Life Sciences (EM) was US$0.01. Over the last year, MYND Life Sciences (EM) shares have traded in a share price range of US$ 0.0073 to US$ 0.03.

MYND Life Sciences (EM) currently has 74,547,806 shares in issue. The market capitalisation of MYND Life Sciences (EM) is US$603,837.23 . MYND Life Sciences (EM) has a price to earnings ratio (PE ratio) of -6.02.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.0081	0.0081	0.0081	0	0	CS
26	0	0	0.0081	0.0081	0.0081	357	0.0081	CS
52	-0.021175	-72.3313407344	0.029275	0.03	0.0073	1210	0.01407514	CS
156	-0.0179	-68.8461538462	0.026	0.0723	0.0073	3918	0.02542002	CS
260	-0.7268	-98.8978092257	0.7349	1.1	0.0073	3075	0.06691542	CS

MYNDF - Frequently Asked Questions (FAQ)

What is the current MYND Life Sciences Inc (EM) share price?

The current share price of MYND Life Sciences Inc (EM) is US$ 0.0081

How many MYND Life Sciences Inc (EM) shares are in issue?

MYND Life Sciences Inc (EM) has 74,547,806 shares in issue

What is the market cap of MYND Life Sciences Inc (EM)?

The market capitalisation of MYND Life Sciences Inc (EM) is USD 603.84k

What is the 1 year trading range for MYND Life Sciences Inc (EM) share price?

MYND Life Sciences Inc (EM) has traded in the range of US$ 0.0073 to US$ 0.03 during the past year

What is the PE ratio of MYND Life Sciences Inc (EM)?

The price to earnings ratio of MYND Life Sciences Inc (EM) is -6.02

What is the cash to sales ratio of MYND Life Sciences Inc (EM)?

The cash to sales ratio of MYND Life Sciences Inc (EM) is 5.22M

What is the registered address of MYND Life Sciences Inc (EM)?

The registered address for MYND Life Sciences Inc (EM) is Unit 150, Port Coquitlam, British Columbia, V3C 2B2

What is the MYND Life Sciences Inc (EM) website address?

The website address for MYND Life Sciences Inc (EM) is www.myndsciences.com

Which industry sector does MYND Life Sciences Inc (EM) operate in?

MYND Life Sciences Inc (EM) operates in the Biotechnology & Life Sciences sector

Hoghead7

Hoghead7 3分前

I like making random guesses and end up being wrong most of the time. I guess I overstimate the market's ability to see and understand what I say. Lol. Yesterday I called support above $15 primarily based on that being about a 1 billion dollar market cap. Today I'll call support at or above $17

BIOChecker4

BIOChecker4 3分前

Read Missling’s employment agreement. Being wrong about thinking small trials would be sufficient to get approval is not grounds for being fired for cause.

fly123

Component 3: The AI-Accelerated Licensing Pipeline (Rival & Sync)
The Rival partnership targets placements ranging from $10,000 to $225,000 per track.4 Assuming HWAL's AI-enhanced metadata tagging (via Claude Opus 4.8) and micro-licensing portal (via ChatGPT 5.5) successfully accelerates this

Monksdream

Monksdream 4分前

AZI! There it goes

Porch Honkey

Porch Honkey 4分前

Wrong board, but nice try, lol.

BigJuan

BigJuan 4分前

They just need to push a change of control here…. more 1 share volume BS here today.

Investor082

Investor082 4分前

Is that why NWBO hasn’t submitted BLA to FDA almost 6 years since data lock? Or for that matter to any other regulatory agency outside the tiny UK and that too without reimbursement evidence?

No excuses when LP continues to dilute in pennies throughout the year, OK? LOL! ;)

fredscott36

fredscott36 5分前

but for all we know we aren't

....

Porch Honkey

Porch Honkey 5分前

You aint getting my shares, but nice try, lol.

100lbStriper

100lbStriper 5分前

Anticipated ITC Timeline https://www.mofo.com/itc/itc-lifecycle

DayTr

GOING BACK TO $3. Trump lied about release. They don't know what to do, FHFA director taking job as intelligent and ABANDONED Fannie/Freddie.

Don't come crying on this board when it goes back to $3. You have been warned.

nowwhat2

nowwhat2 5分前

Eviscerating the clueless......Just slashing their guts out.

https://investorshub.advfn.com/uimage/uploads/2026/6/9/lvhlcBTC_JUNE_9_10Y_730am_THRU_200_SNIP_TEMP.jpg

YESTERDAY ETHEREUM
https://investorshub.advfn.com/uimage/uploads/2026/6/9/

Lone Clone

Lone Clone 5分前

Camecp/CanAlaska Begin Summer Drill Program at West McArthur Joint Venture

Drilling Focused on Continued Step Outs to Evaluate Trend for Additional Zones of High-Grade Uranium Mineralization

Anticipate 20 to 25 Unconformity Target Tests in Fully Funded Summer Program

fly123

Component 1: The Legacy Music Catalog (Melody Trust)
The foundational value of the enterprise lies in the 27,000 master recordings. Utilizing Reservoir Media (RSVR) as a public market benchmark—which commands a $682 million market cap generating $175.7 million in annual revenue primarily off

jesster64

jesster64 5分前

I agree with you. Of the 2, which side is frequently filing for extensions and experiencing delays? MHRA reputation is based on reasonable turnaround from application to decision.

Jack_Bolander

Jack_Bolander 6分前

BB - Name one data center running on Green Hydrogen.

I can name 700+ running on Fossil Fuels.

Kentucky123

Kentucky123 6分前

Right now the problem is silence. We speculate as to why. Mayo said it was the lawyers. What did Missling do to be fired for cause. Not pay bills? Take kickbacks from Lincoln. Seuxal harassment.? Falsify data? Who knows?
Breaking below 2.50 opens up 2 and below.

ExtremelyBullishZig

ExtremelyBullishZig 6分前

Anavex must have had their anti-aging formulas stolen.... I thought we were the only people with the life-altering anti-aging serum that could be taken by pill form, but apparently someone had to have stolen it and made it in the form of an injection....https://www.yahoo.com/news/science/articles/fi

vlispxpert

vlispxpert 6分前

amazing, I'm green because Food sector safety flight incoming ;)

creakyhottie

creakyhottie 6分前

Here is Grok so it wins 2-1

Yes, Ondas Holdings (ONDS) made the preliminary list for inclusion in the Russell 2000 Index as part of the June 2026 semi-annual reconstitution.

lseg.com

It was added to the preliminary Russell 3000 additions (which feeds

midas98

midas98 6分前

LOL, thanks - We will see what the next segment has in store for me

oldstocks

oldstocks 7分前

Company News
Posts Coming Soon
https://www.mingothings.com/blog/categories/news

As we wait for investor share price support

We got a long way to go only up 2.41% today

fly123

Component 2: Lunar Records Fund #1 (Web3 Tokenization)
The Momentum Media Fund (MMF) provided a pro forma market capitalization analysis for Lunar Records Fund #1, based exclusively on the securitization of the first 1,000 of the 26,000 songs, alongside projected multivers

fly123

Price Target Calculation: Dividing the Total Target Enterprise Value of $716,000,000 by the verified
145,353,737 outstanding shares 15 yields a Target Price of $4.92 per share. While an ascent from current
levels near $0.125 to $4.92 represents an astronomical percentage gain, it is cr

Just give me $1.50

Just give me $1.50 7分前

Even Jim Carrey is now making fun of The Rat:

https://www.youtube.com/watch?v=9o7LPaMqFP8

MYND Life Sciences (EM)

iShares VII PLC iShares ... (EM)

No Borders (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。